- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The CAR-T Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global CAR-T Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Acute Lymphocytic Leukemia accounting for % of the CAR-T Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While CD19 segment is altered to a % CAGR between 2022 and 2028.
Global key companies of CAR-T Therapy include Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, and Celgene Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
CAR-T Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CD19
CD22
Other
Market segment by Application, can be divided into
Acute Lymphocytic Leukemia
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Chronic Lymphocytic Leukemia
Multiple Myeloma
Other
Market segment by players, this report covers
Novartis AG
Kite Pharma
Pfizer
Juno Therapeutics
Celgene Corporation
CARsgen Therapeutics
Sorrento Therapeutics
Legend Biotech
Atara Biotherapeutics
Aurora Biopharma
Autolus Therapeutics PLC
Bluebird
Carina Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe CAR-T Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of CAR-T Therapy, with revenue, gross margin and global market share of CAR-T Therapy from 2019 to 2022.
Chapter 3, the CAR-T Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and CAR-T Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe CAR-T Therapy research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of CAR-T Therapy
1.2 Classification of CAR-T Therapy by Type
1.2.1 Overview: Global CAR-T Therapy Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global CAR-T Therapy Revenue Market Share by Type in 2021
1.2.3 CD19
1.2.4 CD22
1.2.5 Other
1.3 Global CAR-T Therapy Market by Application
1.3.1 Overview: Global CAR-T Therapy Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Acute Lymphocytic Leukemia
1.3.3 Diffuse Large B Cell Lymphoma
1.3.4 Follicular Lymphoma
1.3.5 Chronic Lymphocytic Leukemia
1.3.6 Multiple Myeloma
1.3.7 Other
1.4 Global CAR-T Therapy Market Size & Forecast
1.5 Global CAR-T Therapy Market Size and Forecast by Region
1.5.1 Global CAR-T Therapy Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global CAR-T Therapy Market Size by Region, (2017-2022)
1.5.3 North America CAR-T Therapy Market Size and Prospect (2017-2028)
1.5.4 Europe CAR-T Therapy Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific CAR-T Therapy Market Size and Prospect (2017-2028)
1.5.6 South America CAR-T Therapy Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa CAR-T Therapy Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 CAR-T Therapy Market Drivers
1.6.2 CAR-T Therapy Market Restraints
1.6.3 CAR-T Therapy Trends Analysis
2 Company Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG CAR-T Therapy Product and Solutions
2.1.4 Novartis AG CAR-T Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Novartis AG Recent Developments and Future Plans
2.2 Kite Pharma
2.2.1 Kite Pharma Details
2.2.2 Kite Pharma Major Business
2.2.3 Kite Pharma CAR-T Therapy Product and Solutions
2.2.4 Kite Pharma CAR-T Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Kite Pharma Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer CAR-T Therapy Product and Solutions
2.3.4 Pfizer CAR-T Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Juno Therapeutics
2.4.1 Juno Therapeutics Details
2.4.2 Juno Therapeutics Major Business
2.4.3 Juno Therapeutics CAR-T Therapy Product and Solutions
2.4.4 Juno Therapeutics CAR-T Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Juno Therapeutics Recent Developments and Future Plans
2.5 Celgene Corporation
2.5.1 Celgene Corporation Details
2.5.2 Celgene Corporation Major Business
2.5.3 Celgene Corporation CAR-T Therapy Product and Solutions
2.5.4 Celgene Corporation CAR-T Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Celgene Corporation Recent Developments and Future Plans
2.6 CARsgen Therapeutics
2.6.1 CARsgen Therapeutics Details
2.6.2 CARsgen Therapeutics Major Business
2.6.3 CARsgen Therapeutics CAR-T Therapy Product and Solutions
2.6.4 CARsgen Therapeutics CAR-T Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 CARsgen Therapeutics Recent Developments and Future Plans
2.7 Sorrento Therapeutics
2.7.1 Sorrento Therapeutics Details
2.7.2 Sorrento Therapeutics Major Business
2.7.3 Sorrento Therapeutics CAR-T Therapy Product and Solutions
2.7.4 Sorrento Therapeutics CAR-T Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Sorrento Therapeutics Recent Developments and Future Plans
2.8 Legend Biotech
2.8.1 Legend Biotech Details
2.8.2 Legend Biotech Major Business
2.8.3 Legend Biotech CAR-T Therapy Product and Solutions
2.8.4 Legend Biotech CAR-T Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Legend Biotech Recent Developments and Future Plans
2.9 Atara Biotherapeutics
2.9.1 Atara Biotherapeutics Details
2.9.2 Atara Biotherapeutics Major Business
2.9.3 Atara Biotherapeutics CAR-T Therapy Product and Solutions
2.9.4 Atara Biotherapeutics CAR-T Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Atara Biotherapeutics Recent Developments and Future Plans
2.10 Aurora Biopharma
2.10.1 Aurora Biopharma Details
2.10.2 Aurora Biopharma Major Business
2.10.3 Aurora Biopharma CAR-T Therapy Product and Solutions
2.10.4 Aurora Biopharma CAR-T Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Aurora Biopharma Recent Developments and Future Plans
2.11 Autolus Therapeutics PLC
2.11.1 Autolus Therapeutics PLC Details
2.11.2 Autolus Therapeutics PLC Major Business
2.11.3 Autolus Therapeutics PLC CAR-T Therapy Product and Solutions
2.11.4 Autolus Therapeutics PLC CAR-T Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Autolus Therapeutics PLC Recent Developments and Future Plans
2.12 Bluebird
2.12.1 Bluebird Details
2.12.2 Bluebird Major Business
2.12.3 Bluebird CAR-T Therapy Product and Solutions
2.12.4 Bluebird CAR-T Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Bluebird Recent Developments and Future Plans
2.13 Carina Biotech
2.13.1 Carina Biotech Details
2.13.2 Carina Biotech Major Business
2.13.3 Carina Biotech CAR-T Therapy Product and Solutions
2.13.4 Carina Biotech CAR-T Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Carina Biotech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global CAR-T Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 CAR-T Therapy Players Market Share in 2021
3.2.2 Top 10 CAR-T Therapy Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 CAR-T Therapy Players Head Office, Products and Services Provided
3.4 CAR-T Therapy Mergers & Acquisitions
3.5 CAR-T Therapy New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global CAR-T Therapy Revenue and Market Share by Type (2017-2022)
4.2 Global CAR-T Therapy Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global CAR-T Therapy Revenue Market Share by Application (2017-2022)
5.2 Global CAR-T Therapy Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America CAR-T Therapy Revenue by Type (2017-2028)
6.2 North America CAR-T Therapy Revenue by Application (2017-2028)
6.3 North America CAR-T Therapy Market Size by Country
6.3.1 North America CAR-T Therapy Revenue by Country (2017-2028)
6.3.2 United States CAR-T Therapy Market Size and Forecast (2017-2028)
6.3.3 Canada CAR-T Therapy Market Size and Forecast (2017-2028)
6.3.4 Mexico CAR-T Therapy Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe CAR-T Therapy Revenue by Type (2017-2028)
7.2 Europe CAR-T Therapy Revenue by Application (2017-2028)
7.3 Europe CAR-T Therapy Market Size by Country
7.3.1 Europe CAR-T Therapy Revenue by Country (2017-2028)
7.3.2 Germany CAR-T Therapy Market Size and Forecast (2017-2028)
7.3.3 France CAR-T Therapy Market Size and Forecast (2017-2028)
7.3.4 United Kingdom CAR-T Therapy Market Size and Forecast (2017-2028)
7.3.5 Russia CAR-T Therapy Market Size and Forecast (2017-2028)
7.3.6 Italy CAR-T Therapy Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific CAR-T Therapy Revenue by Type (2017-2028)
8.2 Asia-Pacific CAR-T Therapy Revenue by Application (2017-2028)
8.3 Asia-Pacific CAR-T Therapy Market Size by Region
8.3.1 Asia-Pacific CAR-T Therapy Revenue by Region (2017-2028)
8.3.2 China CAR-T Therapy Market Size and Forecast (2017-2028)
8.3.3 Japan CAR-T Therapy Market Size and Forecast (2017-2028)
8.3.4 South Korea CAR-T Therapy Market Size and Forecast (2017-2028)
8.3.5 India CAR-T Therapy Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia CAR-T Therapy Market Size and Forecast (2017-2028)
8.3.7 Australia CAR-T Therapy Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America CAR-T Therapy Revenue by Type (2017-2028)
9.2 South America CAR-T Therapy Revenue by Application (2017-2028)
9.3 South America CAR-T Therapy Market Size by Country
9.3.1 South America CAR-T Therapy Revenue by Country (2017-2028)
9.3.2 Brazil CAR-T Therapy Market Size and Forecast (2017-2028)
9.3.3 Argentina CAR-T Therapy Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa CAR-T Therapy Revenue by Type (2017-2028)
10.2 Middle East & Africa CAR-T Therapy Revenue by Application (2017-2028)
10.3 Middle East & Africa CAR-T Therapy Market Size by Country
10.3.1 Middle East & Africa CAR-T Therapy Revenue by Country (2017-2028)
10.3.2 Turkey CAR-T Therapy Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia CAR-T Therapy Market Size and Forecast (2017-2028)
10.3.4 UAE CAR-T Therapy Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global CAR-T Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global CAR-T Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market CAR-T Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global CAR-T Therapy Revenue (USD Million) by Region (2017-2022)
Table 5. Global CAR-T Therapy Revenue Market Share by Region (2023-2028)
Table 6. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 7. Novartis AG Major Business
Table 8. Novartis AG CAR-T Therapy Product and Solutions
Table 9. Novartis AG CAR-T Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Kite Pharma Corporate Information, Head Office, and Major Competitors
Table 11. Kite Pharma Major Business
Table 12. Kite Pharma CAR-T Therapy Product and Solutions
Table 13. Kite Pharma CAR-T Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Pfizer Corporate Information, Head Office, and Major Competitors
Table 15. Pfizer Major Business
Table 16. Pfizer CAR-T Therapy Product and Solutions
Table 17. Pfizer CAR-T Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Juno Therapeutics Corporate Information, Head Office, and Major Competitors
Table 19. Juno Therapeutics Major Business
Table 20. Juno Therapeutics CAR-T Therapy Product and Solutions
Table 21. Juno Therapeutics CAR-T Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Celgene Corporation Corporate Information, Head Office, and Major Competitors
Table 23. Celgene Corporation Major Business
Table 24. Celgene Corporation CAR-T Therapy Product and Solutions
Table 25. Celgene Corporation CAR-T Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. CARsgen Therapeutics Corporate Information, Head Office, and Major Competitors
Table 27. CARsgen Therapeutics Major Business
Table 28. CARsgen Therapeutics CAR-T Therapy Product and Solutions
Table 29. CARsgen Therapeutics CAR-T Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Sorrento Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. Sorrento Therapeutics Major Business
Table 32. Sorrento Therapeutics CAR-T Therapy Product and Solutions
Table 33. Sorrento Therapeutics CAR-T Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Legend Biotech Corporate Information, Head Office, and Major Competitors
Table 35. Legend Biotech Major Business
Table 36. Legend Biotech CAR-T Therapy Product and Solutions
Table 37. Legend Biotech CAR-T Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Atara Biotherapeutics Corporate Information, Head Office, and Major Competitors
Table 39. Atara Biotherapeutics Major Business
Table 40. Atara Biotherapeutics CAR-T Therapy Product and Solutions
Table 41. Atara Biotherapeutics CAR-T Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Aurora Biopharma Corporate Information, Head Office, and Major Competitors
Table 43. Aurora Biopharma Major Business
Table 44. Aurora Biopharma CAR-T Therapy Product and Solutions
Table 45. Aurora Biopharma CAR-T Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Autolus Therapeutics PLC Corporate Information, Head Office, and Major Competitors
Table 47. Autolus Therapeutics PLC Major Business
Table 48. Autolus Therapeutics PLC CAR-T Therapy Product and Solutions
Table 49. Autolus Therapeutics PLC CAR-T Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Bluebird Corporate Information, Head Office, and Major Competitors
Table 51. Bluebird Major Business
Table 52. Bluebird CAR-T Therapy Product and Solutions
Table 53. Bluebird CAR-T Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Carina Biotech Corporate Information, Head Office, and Major Competitors
Table 55. Carina Biotech Major Business
Table 56. Carina Biotech CAR-T Therapy Product and Solutions
Table 57. Carina Biotech CAR-T Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global CAR-T Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global CAR-T Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of CAR-T Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. CAR-T Therapy Players Head Office, Products and Services Provided
Table 62. CAR-T Therapy Mergers & Acquisitions in the Past Five Years
Table 63. CAR-T Therapy New Entrants and Expansion Plans
Table 64. Global CAR-T Therapy Revenue (USD Million) by Type (2017-2022)
Table 65. Global CAR-T Therapy Revenue Share by Type (2017-2022)
Table 66. Global CAR-T Therapy Revenue Forecast by Type (2023-2028)
Table 67. Global CAR-T Therapy Revenue by Application (2017-2022)
Table 68. Global CAR-T Therapy Revenue Forecast by Application (2023-2028)
Table 69. North America CAR-T Therapy Revenue by Type (2017-2022) & (USD Million)
Table 70. North America CAR-T Therapy Revenue by Type (2023-2028) & (USD Million)
Table 71. North America CAR-T Therapy Revenue by Application (2017-2022) & (USD Million)
Table 72. North America CAR-T Therapy Revenue by Application (2023-2028) & (USD Million)
Table 73. North America CAR-T Therapy Revenue by Country (2017-2022) & (USD Million)
Table 74. North America CAR-T Therapy Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe CAR-T Therapy Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe CAR-T Therapy Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe CAR-T Therapy Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe CAR-T Therapy Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe CAR-T Therapy Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe CAR-T Therapy Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific CAR-T Therapy Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific CAR-T Therapy Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific CAR-T Therapy Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific CAR-T Therapy Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific CAR-T Therapy Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific CAR-T Therapy Revenue by Region (2023-2028) & (USD Million)
Table 87. South America CAR-T Therapy Revenue by Type (2017-2022) & (USD Million)
Table 88. South America CAR-T Therapy Revenue by Type (2023-2028) & (USD Million)
Table 89. South America CAR-T Therapy Revenue by Application (2017-2022) & (USD Million)
Table 90. South America CAR-T Therapy Revenue by Application (2023-2028) & (USD Million)
Table 91. South America CAR-T Therapy Revenue by Country (2017-2022) & (USD Million)
Table 92. South America CAR-T Therapy Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa CAR-T Therapy Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa CAR-T Therapy Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa CAR-T Therapy Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa CAR-T Therapy Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa CAR-T Therapy Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa CAR-T Therapy Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. CAR-T Therapy Picture
Figure 2. Global CAR-T Therapy Revenue Market Share by Type in 2021
Figure 3. CD19
Figure 4. CD22
Figure 5. Other
Figure 6. CAR-T Therapy Revenue Market Share by Application in 2021
Figure 7. Acute Lymphocytic Leukemia Picture
Figure 8. Diffuse Large B Cell Lymphoma Picture
Figure 9. Follicular Lymphoma Picture
Figure 10. Chronic Lymphocytic Leukemia Picture
Figure 11. Multiple Myeloma Picture
Figure 12. Other Picture
Figure 13. Global CAR-T Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global CAR-T Therapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global CAR-T Therapy Revenue Market Share by Region (2017-2028)
Figure 16. Global CAR-T Therapy Revenue Market Share by Region in 2021
Figure 17. North America CAR-T Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe CAR-T Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific CAR-T Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America CAR-T Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa CAR-T Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. CAR-T Therapy Market Drivers
Figure 23. CAR-T Therapy Market Restraints
Figure 24. CAR-T Therapy Market Trends
Figure 25. Novartis AG Recent Developments and Future Plans
Figure 26. Kite Pharma Recent Developments and Future Plans
Figure 27. Pfizer Recent Developments and Future Plans
Figure 28. Juno Therapeutics Recent Developments and Future Plans
Figure 29. Celgene Corporation Recent Developments and Future Plans
Figure 30. CARsgen Therapeutics Recent Developments and Future Plans
Figure 31. Sorrento Therapeutics Recent Developments and Future Plans
Figure 32. Legend Biotech Recent Developments and Future Plans
Figure 33. Atara Biotherapeutics Recent Developments and Future Plans
Figure 34. Aurora Biopharma Recent Developments and Future Plans
Figure 35. Autolus Therapeutics PLC Recent Developments and Future Plans
Figure 36. Bluebird Recent Developments and Future Plans
Figure 37. Carina Biotech Recent Developments and Future Plans
Figure 38. Global CAR-T Therapy Revenue Share by Players in 2021
Figure 39. CAR-T Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 40. Global Top 3 Players CAR-T Therapy Revenue Market Share in 2021
Figure 41. Global Top 10 Players CAR-T Therapy Revenue Market Share in 2021
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 43. Global CAR-T Therapy Revenue Share by Type in 2021
Figure 44. Global CAR-T Therapy Market Share Forecast by Type (2023-2028)
Figure 45. Global CAR-T Therapy Revenue Share by Application in 2021
Figure 46. Global CAR-T Therapy Market Share Forecast by Application (2023-2028)
Figure 47. North America CAR-T Therapy Sales Market Share by Type (2017-2028)
Figure 48. North America CAR-T Therapy Sales Market Share by Application (2017-2028)
Figure 49. North America CAR-T Therapy Revenue Market Share by Country (2017-2028)
Figure 50. United States CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe CAR-T Therapy Sales Market Share by Type (2017-2028)
Figure 54. Europe CAR-T Therapy Sales Market Share by Application (2017-2028)
Figure 55. Europe CAR-T Therapy Revenue Market Share by Country (2017-2028)
Figure 56. Germany CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific CAR-T Therapy Sales Market Share by Type (2017-2028)
Figure 62. Asia-Pacific CAR-T Therapy Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific CAR-T Therapy Revenue Market Share by Region (2017-2028)
Figure 64. China CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South Korea CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America CAR-T Therapy Sales Market Share by Type (2017-2028)
Figure 71. South America CAR-T Therapy Sales Market Share by Application (2017-2028)
Figure 72. South America CAR-T Therapy Revenue Market Share by Country (2017-2028)
Figure 73. Brazil CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East and Africa CAR-T Therapy Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa CAR-T Therapy Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa CAR-T Therapy Revenue Market Share by Country (2017-2028)
Figure 78. Turkey CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. UAE CAR-T Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
